UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid‐derived suppressor cells

Journal of leukocyte biology, 2018-03, Vol.103 (3), p.395-407

2018

Volltextzugriff (PDF)

Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells

Cancer research (Chicago, Ill.), 2007-05, Vol.67 (9), p.4507-4513

2007

Volltextzugriff (PDF)

HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (20), p.5723-5733

2014

Volltextzugriff (PDF)

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response

Journal of Immunology, 2007-07, Vol.179 (2), p.977-983

2007

Volltextzugriff (PDF)

Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4

Journal of leukocyte biology, 2009-06, Vol.85 (6), p.996-1004

2009

Volltextzugriff (PDF)

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression

Cancer research (Chicago, Ill.), 2007-10, Vol.67 (20), p.10019-10026

2007

Volltextzugriff (PDF)

Frontline Science: Myeloid‐derived suppressor cells (MDSCs) facilitate maternal–fetal tolerance in mice

Journal of leukocyte biology, 2017-05, Vol.101 (5), p.1091-1101

2017

Volltextzugriff (PDF)

Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease

The Journal of immunology (1950), 2005-01, Vol.174 (2), p.636-645

2005

Volltextzugriff (PDF)

Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease

Cancer research (Chicago, Ill.), 2004-03, Vol.64 (6), p.2205-2211

2004

Volltextzugriff (PDF)

Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine

Cancer research (Chicago, Ill.), 2010-01, Vol.70 (1), p.68-77

2010

Volltextzugriff (PDF)

Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression

Seminars in cancer biology, 2012-08, Vol.22 (4), p.275-281

2012

Volltextzugriff (PDF)

Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells

The Journal of immunology (1950), 2009-07, Vol.183 (2), p.937-944

2009

Volltextzugriff (PDF)

Differential Content of Proteins, mRNAs, and miRNAs Suggests that MDSC and Their Exosomes May Mediate Distinct Immune Suppressive Functions

Journal of proteome research, 2018-01, Vol.17 (1), p.486-498

2018

Volltextzugriff (PDF)

Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression

Journal of Immunology, 2006-01, Vol.176 (1), p.284-290

2006

Volltextzugriff (PDF)

Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (24), p.11743-11751

2005

Volltextzugriff (PDF)

Cutting Edge: STAT6-Deficient Mice Have Enhanced Tumor Immunity to Primary and Metastatic Mammary Carcinoma

The Journal of immunology (1950), 2000-12, Vol.165 (11), p.6015-6019

2000

Volltextzugriff (PDF)

Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell–expressed FasL

Blood, 2011-05, Vol.117 (20), p.5381-5390

2011

Volltextzugriff (PDF)

CD3xPDL1 bi-specific T cell engager (BiTE) simultaneously activates T cells and NKT cells, kills PDL1 + tumor cells, and extends the survival of tumor-bearing humanized mice

Oncotarget, 2017-08, Vol.8 (35), p.57964-57980

2017

Volltextzugriff (PDF)

Ubiquitin Conjugation Probed by Inflammation in Myeloid-Derived Suppressor Cell Extracellular Vesicles

Journal of proteome research, 2018-01, Vol.17 (1), p.315-324

2018

Volltextzugriff (PDF)

Major Histocompatibility Complex Class II-Transfected Tumor Cells Present Endogenous Antigen and are Potent Inducers of Tumor-Specific Immunity

Proceedings of the National Academy of Sciences - PNAS, 1997-06, Vol.94 (13), p.6886-6891

1997

Volltextzugriff (PDF)

Tumor immunity : a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression

Cancer Immunology, Immunotherapy, 2005-11, Vol.54 (11), p.1137-1142

2005

Volltextzugriff (PDF)

Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent

The Journal of immunology (1950), 2002-11, Vol.169 (10), p.5796-5804

2002

Volltextzugriff (PDF)

The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes

Cancer Immunology, Immunotherapy, 2008-03, Vol.57 (3), p.389-398

2008

Volltextzugriff (PDF)

Activation of tumor-specific CD4+ T lymphocytes by major histocompatibility complex class II tumor cell vaccines: A novel cell-based immunotherapy

Cancer research (Chicago, Ill.), 2004-03, Vol.64 (5), p.1867-1874

2004

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(76)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(53)
Humans
(35)
Animals
(33)
Female
(30)
Biological And Medical Sciences
(29)
Mice
(29)
Medical Sciences
(26)
Male
(24)
Immunology
(20)
Mice, Inbred Balb C
(17)
Adult
(15)
Middle Aged
(14)
Oncology
(14)
Mammary Neoplasms, Experimental - Immunology
(12)
Pharmacology. Drug Treatments
(12)
Rheumatology
(12)
Tumors
(12)
Scleroderma, Systemic - Drug Therapy
(11)
Treatment Outcome
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid‐derived suppressor cells

Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells

HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response

Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression

Frontline Science: Myeloid‐derived suppressor cells (MDSCs) facilitate maternal–fetal tolerance in mice

Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease

Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes

Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease

Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine

Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression

Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells

Differential Content of Proteins, mRNAs, and miRNAs Suggests that MDSC and Their Exosomes May Mediate Distinct Immune Suppressive Functions

Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression

Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis

Cutting Edge: STAT6-Deficient Mice Have Enhanced Tumor Immunity to Primary and Metastatic Mammary Carcinoma

Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell–expressed FasL

CD3xPDL1 bi-specific T cell engager (BiTE) simultaneously activates T cells and NKT cells, kills PDL1 + tumor cells, and extends the survival of tumor-bearing humanized mice

Ubiquitin Conjugation Probed by Inflammation in Myeloid-Derived Suppressor Cell Extracellular Vesicles

Major Histocompatibility Complex Class II-Transfected Tumor Cells Present Endogenous Antigen and are Potent Inducers of Tumor-Specific Immunity

Tumor immunity : a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression

Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent

The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes

Activation of tumor-specific CD4+ T lymphocytes by major histocompatibility complex class II tumor cell vaccines: A novel cell-based immunotherapy

Suchergebnisse filtern